Bauer et al. [77] investigated the anticancer activity of AP against BC cells (MDA-MB-231) and found that it influenced the NF-κB pathway by suppressing the VEGF through deactivating progesterone receptors in BC cells. This evidence concerns the gene VEGFA and breast cancer.